Skip to main content
. 2009 Dec 28;28(4):605–613. doi: 10.1200/JCO.2009.23.4781

Fig 2.

Fig 2.

The DNA methylation prognostic model and cytogenetic risk groups. The Kaplan-Meier estimates show survivals for groups of patients with cytogenetic good risk (A: overall survival; D: progression-free survivals), intermediate risk (B: overall survival; E: progression-free survival), and high risk (C: overall survival; F: progression-free survival).